Long-term Effect of tDCS in Patients With Disorders of Consciousness

NCT03114397 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2022-11-03

No results posted yet for this study

Summary

In this multicentric double-blind sham controlled study, the investigators plan to assess the effects of 20 sessions of tDCS on long-term behavioral recovery in patients with disorders of consciousness. Neurophysiological outcomes (EEG) will also be collected.

This research will 1) determine whether long-term behavioral recovery can be promoted with tDCS and 2) generate knowledge regarding the impact of tDCS on neurophysiological outcome (i.e., EEG) in severely brain injured patients. The investigators will compare the effects of active and sham tDCS on behavioral assessments and quantitative EEG in patients with severe brain injury and its potential application in rehabilitation.

Conditions

  • Disorder of Consciousness

Interventions

DEVICE

transcranial direct current stimulation - active

transcranial direct current stimulation will be applied over the left dorsolateral at 2 mA for 20minutes.

DEVICE

transcranial direct current stimulation - sham

transcranial direct current stimulation will be applied over the left dorsolateral at 2 mA for 20minutes. The sham intervention consists of 30 seconds of stimulation at the beginning and the end of the 20minutes of intervention.

Sponsors & Collaborators

  • Fondazione Salvatore Maugeri, Italy

    collaborator UNKNOWN
  • Université Catholique de Louvain, Belgium

    collaborator UNKNOWN
  • Hospitales Nisa, Spain

    collaborator UNKNOWN
  • I.R.C.C.S. Fondazione Santa Lucia, Italy

    collaborator UNKNOWN
  • Schoen Clinic Bad Aibling, Germany

    collaborator UNKNOWN
  • Research Center of Neurology, Russia

    collaborator OTHER_GOV
  • Therapiezentrum Burgau, Germany

    collaborator UNKNOWN
  • pavlov state medical university, Russia

    collaborator UNKNOWN
  • Azienda Unita Sanitaria Locale di Piacenza, Italy

    collaborator UNKNOWN
  • University of Liege

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-01
Primary Completion
2021-12-24
Completion
2021-12-24

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03114397 on ClinicalTrials.gov